The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19.

Pessoa-Amorim G., Mafham MM.

DOI

10.1093/cvr/cvab239

Type

Journal article

Journal

Cardiovasc Res

Publication Date

27/07/2021

Volume

117

Pages

e110 - e113

Keywords

Antithrombotic, Antiviral, COVID-19, Immunomodulation, Randomized trial, Aged, Anti-Inflammatory Agents, Antiviral Agents, COVID-19, Cardiovascular Diseases, Cause of Death, Female, Fibrinolytic Agents, Heart Disease Risk Factors, Humans, Male, Middle Aged, Research Design, Risk Assessment, Time Factors, Treatment Outcome

Permalink Original publication